- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Second Hospital of Jilin University
I alt 21506 resultater
-
Second Xiangya Hospital of Central South UniversityUkendtPrimær vinkellukkende glaukomKina
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityUkendtLevercirrhose | Portal hypertensionKina
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityUkendtPerioperativt blodsukker og insulinKina
-
The First Hospital of Jilin UniversityThe Second Hospital of Hebei Medical University; Second Affiliated Hospital... og andre samarbejdspartnereAktiv, ikke rekrutterende
-
GeneScience Pharmaceuticals Co., Ltd.Peking University First Hospital; Peking University People's Hospital; Qilu... og andre samarbejdspartnereAfsluttet
-
The First Hospital of Jilin UniversityFirst Affiliated Hospital of Shantou University Medical CollegeAfsluttet
-
Tianjin Medical University Second HospitalRekrutteringHer2 Overudtrykkende højrisiko ikke-muskelinvasiv blæreurothelial carcinomKina
-
West China Second University HospitalRekrutteringStråling enteritisKina
-
Tianjin Medical University Second HospitalIkke rekrutterer endnuNyrecellekarcinom | Klarcellet nyrecellekarcinomKina
-
West China Second University HospitalRekrutteringNeoadjuverende kemoterapi | Epitelkarcinom, ovarieKina
-
Tianjin Medical University Second HospitalRekrutteringKastrationsresistent prostatakræft | Prostatakræft MetastatiskKina
-
Tianjin Medical University Second HospitalAktiv, ikke rekrutterendePerioperativ Tislelizumab kombineret med Nab-Paclitaxel til muskel-invasivt urothelial blærecarcinomUrothelialt karcinom | Muskelinvasiv blærekræftKina
-
Tianjin Medical University Second HospitalUkendtSmåcellet lungekræft omfattende stadieKina
-
Tianjin Medical University Second HospitalUkendtSolid tumor, voksenKina
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUkendtIkke-småcellet lungekræft | EGFR-aktiverende mutation | Leptomeningeal metastaseKina
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUkendtIkke-småcellet lungekræft | EGFR-genmutationKina
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUkendtIkke-småcellet lungekræft | EGFR-aktiverende mutation | Leptomeningeal metastase
-
West China Second University HospitalRekruttering
-
West China Second University HospitalRekrutteringLivmoderhalskræftKina
-
Tianjin Medical University Second HospitalRekrutteringRefraktære faste tumorer | Næste generations sekvenseringKina
-
Tianjin Medical University Second HospitalRekrutteringSolid tumor | EGFR amplifikationKina
-
Tianjin Medical University Second HospitalRekruttering
-
Tianjin Medical University Second HospitalRekruttering
-
Tianjin Medical University Second HospitalRekruttering
-
Tianjin Medical University Second HospitalRekruttering
-
West China Second University HospitalIkke rekrutterer endnuTilbagevendende kræft i æggestokkeneKina
-
Tianjin Medical University Second HospitalRekrutteringUrothelial carcinom i blærenKina
-
West China Second University HospitalIkke rekrutterer endnuStrålingsinduceret dermatitisKina
-
Tianjin Medical University Second HospitalIkke rekrutterer endnuUrogenitale neoplasmer | Urothelialt karcinom | Antineoplastiske midler | Gemcitabin | Cisplatin | Anlotinib | CarboplatinKina
-
West China Second University HospitalAktiv, ikke rekrutterendeUterin sarkom | Uterin fibroid | Uterin leiomyosarkomKina
-
Tianjin Medical University Second HospitalUkendt
-
West China Second University HospitalAfsluttet
-
Tianjin Medical University Second HospitalUkendt
-
West China Second University HospitalUkendtArbejdskraft; Tvunget eller induceret, påvirker fosteret eller nyfødtKina
-
University Hospital OstravaUniversity of Ostrava; Hospital Podlesi; Hospital Novy JicinAfsluttet
-
Second Affiliated Hospital of Nanchang UniversityZhejiang UniversityIkke rekrutterer endnu
-
Second Affiliated Hospital of Nanchang UniversityNanchang UniversityUkendtIkke småcellet lungekræft | HjernemetastaserKina
-
West China Second University HospitalRekrutteringImmune Checkpoint-hæmmere, kardiotoksicitetKina
-
Tianjin Medical University Second HospitalRekrutteringMalignt pleural mesotheliom, avanceretKina
-
Tianjin Medical University Second HospitalRekrutteringSolid tumor | FGF-receptorgenmutation | FGF amplifikation | FGF-receptorgenfamilieomlægning | FGF-receptorgentranslokationKina
-
Tianjin Medical University Second HospitalRekruttering
-
Tianjin Medical University Second HospitalRekrutteringHøjrisiko ikke-muskelinvasiv blæreurothelial carcinomKina
-
Tianjin Medical University Second HospitalRekrutteringMuskelinvasiv blærekræft Urothelial karcinomKina
-
Tianjin Medical University Second HospitalIkke rekrutterer endnuNyrecellekarcinom | Klarcellet nyrecellekarcinomKina
-
Tianjin Medical University Second HospitalRekrutteringIkke-muskelinvasiv blæreurothelial karcinom | Høj risikoKina
-
Tianjin Medical University Second HospitalIkke rekrutterer endnuLungeneoplasmer | Oligometastase
-
West China Second University HospitalRekrutteringAtypisk endometriehyperplasi | EndometriecancerKina
-
Tianjin Medical University Second HospitalAfsluttet
-
Tianjin Medical University Second HospitalUkendt
-
West China Second University HospitalAfsluttet